Global Histone Deacetylase Inhibitors market size is expected to reach $1.71 billion by 2029 at 7.2%, segmented as inhibitors, sirtuin 2 (sirt
Read More
Global Guillain-Barre Syndrome Drugs market size is expected to reach $1.64 billion by 2029 at 7.0%, segmented as by immunoglobulins (ivig), intravenous immunoglobulin (ivig) therapy, human normal immunoglobulin (hnig)
Read More
Global Cholinesterase (ChE) Inhibitors market size is expected to reach $5.58 billion by 2029 at 7.4%, increasing prevalence of alzheimer’s disease driving market growth
Read More
Global Gastroparesis Drugs market size is expected to reach $7.04 billion by 2029 at 5.4%, segmented as over-the-counter (otc) drugs, antacids, anti-nausea medications, antiemetics, digestive enzyme supplements
Read More
Global Epilepsy Drugs market size is expected to reach $14.71 billion by 2029 at 7.2%, segmented as by focal seizures, simple focal seizures, complex focal seizures
Read More
Global Dipeptide Peptidase 4 Inhibitors market size is expected to reach $14.21 billion by 2029 at 4.7%, segmented as by type, sitagliptin, saxagliptin, linagliptin, alogliptin, vildagliptin, others types
Read More
Global CD40 Ligand (CD40L) Antibody market size is expected to reach $1.01 billion by 2029 at 10.0%, impact of rising autoimmune disorders on therapeutic advancements
Read More
Global Dental Sleep Medicine market size is expected to reach $8.12 billion by 2029 at 6.9%, segmented as by diagnostic, polysomnography (sleep study), home sleep apnea testing (hsat), sleep disorder screening tools, sleep oximeters
Read More
Global Cytotoxic Drugs market size is expected to reach $19.66 billion by 2029 at 5.1%, segmented as by alkylating agents, nitrogen mustards, ethyleneimines, alkyl sulfonates, triazenes
Read More
Global CD-19 Antibody market size is expected to reach $2.64 billion by 2029 at 8.6%, rising b-cell malignancies to drive growth in the market
Read More